# Executive Summary: Healthcare Treatment Optimization System

**Author:** Horacio Fonseca, Data Analyst
**Date:** January 2025
**Project Type:** Monte Carlo Clinical Decision Support Application

---

## Problem Statement

Healthcare providers face treatment selection decisions with incomplete information, where published efficacy rates represent population averages rather than individual predictions. Patient heterogeneity in age, comorbidities, and disease severity creates outcome variability that deterministic clinical guidelines fail to capture. Complication costs can exceed base treatment expenses by 300%, yet traditional protocols provide no probabilistic risk assessment.

## Solution Approach

This project implements Monte Carlo simulation with 10,000+ scenarios per patient, comparing three treatment modalities: Standard Care (established protocol), New Medication (higher efficacy, increased side effects), and Experimental Therapy (uncertain outcomes, lower complications). The model adjusts efficacy using Beta probability distributions and incorporates patient-specific risk factors including age, severity score, and comorbidities to generate personalized outcome predictions.

## Methodology: Synthetic Data Generation

Instead of searching for static patient datasets (which face HIPAA privacy concerns, limited sample sizes, and outdated snapshots), this project employs **synthetic patient generation** based on actual medical distributions. This approach is standard practice in Monte Carlo simulation research because it:

1. **Enables controlled experimentation** - Define and test specific population parameters
2. **Eliminates data privacy issues** - No HIPAA violations or patient information exposure
3. **Provides unlimited samples** - Generate 100 to 100,000+ patients on demand
4. **Maintains statistical validity** - Uses real medical distributions from clinical trials and population health data
5. **Supports reproducibility** - Identical synthetic cohorts for academic validation

The `data_generator.py` module creates realistic patients using probability distributions calibrated to clinical trial data, CDC population health statistics, and published medical literature. Each synthetic patient includes age, BMI, blood pressure, glucose levels, HbA1c, disease type, and severity score—all parameters required for accurate treatment outcome modeling.

**Academic Justification:** Published Monte Carlo studies in healthcare, clinical trials, and medical decision analysis routinely use synthetic data to control confounding variables and test sensitivity to distributional assumptions. This methodology is academically rigorous and aligns with simulation best practices in medical research.

## Key Findings

Analysis reveals Treatment B achieves 80% success rates versus 70% for Standard Care, but carries 10% higher complication risk and 2.4× cost. Patient age increases complication rates by 3-5% per decade, while each comorbidity reduces efficacy by 5-7%. Recovery time 90% confidence intervals span 20-30 days, demonstrating significant outcome variability absent from traditional point estimates.

## Business Value

The interactive Streamlit application supports evidence-based treatment selection for physicians, quantified risk counseling for patients, and resource planning for hospital administrators. Monte Carlo methodology provides probability distributions for success rates, recovery timelines, complication risks, and cost projections, enabling stakeholders to make informed decisions with explicit uncertainty quantification rather than relying on population averages.

**Repository:** https://github.com/horacefonseca/healthcare_montecarlo_analysis
**Technology:** Python 3.10, NumPy, Pandas, SciPy, Streamlit, Monte Carlo Simulation
